New diabetes clinical trial: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Published on: January 23, 2024 at 11:00PM
Conditions: Type 2 Diabetes
Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Tirzepatide
Sponsors: Novo Nordisk A/S
Not yet recruiting
https://ift.tt/TKzjl8a